Researchers from the UPC’s Molecular Biotechnology Centre show that a drug for osteoporosis called raloxifene may inhibit molecules involved in the inflammatory processes associated with COVID-19.
New research in the February 2021 issue of JNCCN—Journal of the National Comprehensive Cancer Network examined body mass index (BMI) data for people with HER2-positive early […]
Individual variation in the shape and structure of the Achilles tendon may influence our susceptibility to injury later in life, says a study published today in […]